Skip to main content
. 2017 Nov 22;21(4):325–332. doi: 10.1093/ijnp/pyx097

Figure 1.

Figure 1.

Proportion of participants who first experiences worsening in Concise Associated Symptom Tracking (CAST) domains during the first 6 weeks of the Combining Medications to Enhance Depression Outcomes (CO-MED) trial. Worsening is defined as an increase of ≥1.28 baseline SD at week 1, 2, 4, or 6 in the CAST domains of irritability, anxiety, insomnia, and panic.